Catalent Appoints New Vice President and General Manager for European Softgel Business
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has appointed Robert Beland to the newly created role of Vice President & General Manger of Softgel Technologies in Europe.
Mr Beland’s main focus will be on leading initiatives that accelerate overall growth within the European region, working closely with other members of the Softgel Leadership Team to refine and execute strategy, strengthen business development and commercial activities, while extending Catalent’s best in class development and manufacturing capabilities. He will be based at Catalent’s Cham, Switzerland office.
An executive leader, with more than 25 years’ experience in the services industry, both in the pharma and the vitamins, minerals, and supplements (VMS) space, Mr. Beland’s professional career includes 2 years at Catalent’s St Petersburg, Florida facility as Vice President and General Manager for Nutritionals. In his extensive career he has led European and North American businesses. Most recently, Mr Beland was Executive Vice President and Chief Operating Officer for Ricerca Biosciences.
“Robert’s appointment will help to further strengthen our leadership position in the European softgel market,” commented Dr Aris Gennadios, Catalent’s President of Softgel Technologies. “He will particularly focus on driving commercialisation of our recently launched new technologies across the Rx, consumer health and skin care segments, and coordinating our R&D and supply capabilities at our European sites in France, Germany and Italy.”
Mr Beland holds a bachelor’s degree in Chemistry from Université de Montréal, Montréal, QC, Canada and a degree in health sciences from Collège Jean-de Brébeuf, Outremont, QC, Canada.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance